A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.
Novel drugs are required for the elimination of infections caused by filarial worms, as most commonly used drugs largely target the microfilariae or first stage larvae of these infections. Previous studies, conducted in vitro, have shown that inhibition of Hsp90 kills adult Brugia pahangi. As numero...
Main Authors: | Victoria Gillan, Kerry O'Neill, Kirsty Maitland, Francis M Sverdrup, Eileen Devaney |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-02-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3923716?pdf=render |
Similar Items
-
Hsp-90 and the biology of nematodes
by: Maitland Kirsty, et al.
Published: (2009-10-01) -
Assay strategies for the discovery and validation of therapeutics targeting Brugia pahangi Hsp90.
by: Tony Taldone, et al.
Published: (2010-06-01) -
Attempts to Image the Early Inflammatory Response during Infection with the Lymphatic Filarial Nematode Brugia pahangi in a Mouse Model.
by: Elmarie Myburgh, et al.
Published: (2016-01-01) -
Immunity to filarial nematodes
by: Storey, N.
Published: (1985) -
A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodes.
by: Brendan D Galvin, et al.
Published: (2014-09-01)